Source file signed link, expires in 15 minutes
Extracted text 2
Page 1
Go To English Page
Nomor Surat 050/CS-OPI/VI/2024
Nama Perusahaan PT Organon Pharma Indonesia Tbk
Kode Emiten SCPI
Lampiran 2
Perihal Penyampaian Laporan Tahunan dan Keberlanjutan
Perseroan menyampaikan laporan Tahunan dan Keberlanjutan tahun 2023 dengan periode tahun buku dari 01
Januari 2023 sampai dengan 31 Desember 2023
Apakah Perseroan akan/telah melakukan panggilan Rapat Umum Pemegang Saham Tahunan? (Ya)
Perseroan melakukan panggilan Rapat Umum Pemegang Saham Tahunan pada tanggal 06 Juni 2024
Informasi sebagaimana dimaksud di atas telah dimuat pada Situs Web Perseroan di alamat link
https://www.organon.com/indonesia/wp-content/uploads/sites/7/2024/06/ANNUAL-REPORT-ORGANON-31.pdf pada
Rasio Komposisi:
Jajaran Direksi = 1 Perempuan : 2 Laki-Laki.
Jajaran Level Senior Manajemen = 7 Perempuan : 10 Laki-Laki.
Rata-rata waktu pelatihan Perempuan dan Laki-Laki 30 jam.
Daur Ulang Sampah 78 %.
Demikian untuk diketahui.
Hormat Kami,
PT Organon Pharma Indonesia Tbk
Arie Noviandari
approver dua
PT Organon Pharma Indonesia Tbk
Sinarmas MSIG Tower, Lantai 37, unit 102 & 106, Jalan Jenderal Sudirman Kaveling
Telepon : 085951102178, Fax : 021-31107009, https://www.organon.com/indonesia/
Nama Pengirim Arie Noviandari
Jabatan approver dua
Tanggal dan Waktu 20-06-2024 16:06
Lampiran 1. OPI - Annual Report 2023 .pdf
2. COVER AR ORGANON 2023 FINAL.pdf
Dokumen ini merupakan dokumen resmi PT Organon Pharma Indonesia Tbk yang tidak memerlukan tanda tangan
karena dihasilkan secara elektronik oleh sistem pelaporan elektronik. PT Organon Pharma Indonesia Tbk
bertanggung jawab penuh atas informasi yang tertera didalam dokumen ini.
Page 2
Go To Indonesian Page
Letter / Announcement No. 050/CS-OPI/VI/2024
Issuer Name PT Organon Pharma Indonesia Tbk
Issuer Code SCPI
Attachment 2
Subject Submission of Annual and Continuity Report
The Company hereby submit Annual and Continuity Report 2023 for the period of 01 January 2023 to 31 December
2023 in Indonesia and English
Will the Company be/has summons for the Annual General Meeting of Shareholders? (Yes)
The Company made invitations to the Annual General Meeting of Shareholders on 06 June 2024
The information referred above has been published on the Company’s website
https://www.organon.com/indonesia/wp-content/uploads/sites/7/2024/06/ANNUAL-REPORT-ORGANON-31.pdf at 19
Composition Ratio:
Board of Directors = 1 Woman : 2 Man.
Senior Management Level = 7 Woman : 10 Man.
Recycle 78%.
Thus to be informed accordingly.
Respectfully,
PT Organon Pharma Indonesia Tbk
Arie Noviandari
approver dua
PT Organon Pharma Indonesia Tbk
Sinarmas MSIG Tower, Lantai 37, unit 102 & 106, Jalan Jenderal Sudirman Kaveling
Phone : 085951102178, Fax : 021-31107009, https://www.organon.com/indonesia/
Sender Name Arie Noviandari
Function approver dua
Date and Time 20-06-2024 16:06
Attachment 1. OPI - Annual Report 2023 .pdf
2. COVER AR ORGANON 2023 FINAL.pdf
This is an official document of PT Organon Pharma Indonesia Tbk that does not require a signature as it was
generated electronically by the electronic reporting system. PT Organon Pharma Indonesia Tbk is fully responsible
for the information contained within this document.
Names mentioned 2 people and organisations named in the text · linked when the evidence is strong
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.